{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T22:09:25Z","timestamp":1768774165872,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00011-011-0358-x","type":"journal-article","created":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T09:03:14Z","timestamp":1310202194000},"page":"973-980","source":"Crossref","is-referenced-by-count":28,"title":["Influence of chronic inflammation and autoimmunity on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients"],"prefix":"10.1007","volume":"60","author":[{"given":"Wojciech","family":"Plazak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieczyslaw","family":"Pasowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Kostkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Podolec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Tomkiewicz-Pajak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Musial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Podolec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,10]]},"reference":[{"key":"358_CR1","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/rheumatology\/kei142","volume":"44","author":"IN Bruce","year":"2005","unstructured":"Bruce IN. \u201cNot only\u2026 but also\u201d: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology. 2005;44:1492\u2013502.","journal-title":"Rheumatology"},{"key":"358_CR2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/rheumatology\/kep102","volume":"48","author":"GJ Pons-Estel","year":"2009","unstructured":"Pons-Estel GJ, Gonzales LA, Zhang J, Burgos PI, Reveille JD, Alarcon GS. Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multicenter US cohort. Rheumatology. 2009;48:817\u201322.","journal-title":"Rheumatology"},{"key":"358_CR3","first-page":"219","volume-title":"Rheumatology","author":"AS Wiik","year":"2008","unstructured":"Wiik AS, Fritzler MJ. Laboratory tests in rheumatic disorders. In: Hochberg M, Silman A, Smolen J, Weinblatt M, Weisman M, editors. Rheumatology. Philadelphia: Mosby Elsevier; 2008. p. 219\u201332."},{"key":"358_CR4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780400322","volume":"40","author":"N Papa Del","year":"1997","unstructured":"Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, et al. Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti\u03b22glycoprotein-1 induced endothelial cell activation. Arthritis Rheum. 1997;40:551\u201361.","journal-title":"Arthritis Rheum"},{"key":"358_CR5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.RES.88.2.245","volume":"88","author":"SS Pierangeli","year":"2001","unstructured":"Pierangeli SS, Espinola RG, Liu XW, Harris EN. Thrombogenic effect of antiphospholipid antibodies are mediated by intracellular adhesion molecule-1, vascular cell adhesion molecule-1 and P-selectin. Circ Res. 2001;88:245\u201350.","journal-title":"Circ Res"},{"key":"358_CR6","first-page":"519","volume":"73","author":"AL Campbell","year":"1995","unstructured":"Campbell AL, Pierangeli SS, Wellhausen S, Harris EN. Comparison of the effect of anticardiolipin antibodies from patients with antiphospholipid syndrome and with syphilis on platelet activation and aggregation. Thromb Haemost. 1995;73:519\u201324.","journal-title":"Thromb Haemost"},{"key":"358_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI117657","volume":"95","author":"MD Smirnov","year":"1995","unstructured":"Smirnov MD, Triplett DT, Comp PC, Esmon NL, Esmon CT. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by anti-phospholipid antibodies. J Clin Invest. 1995;95:309\u201316.","journal-title":"J Clin Invest"},{"key":"358_CR8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite anti phospholipid syndrome (APS). J Thromb Haemost. 2006;4:295\u2013306.","journal-title":"J Thromb Haemost"},{"key":"358_CR9","first-page":"1710","volume":"24","author":"J Swadzba","year":"1997","unstructured":"Swadzba J, de Clerck LS, Stevens WJ, Bridts CH, van Cotton KA, Musial J, et al. Anticardiolipin antibodies, anti-\u03b22-glycoprotein I, antiprothrombin antibodies and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol. 1997;24:1710\u20135.","journal-title":"J Rheumatol"},{"key":"358_CR10","first-page":"1205","volume-title":"Rheumatology","author":"J Smolen","year":"2008","unstructured":"Smolen J, Weisman M. Connective tissue disorders. In: Hochberg M, Silman A, Smolen J, Weinblatt M, Weisman M, editors. Rheumatology. Philadelphia: Mosby Elsevier; 2008. p. 1205\u2013485."},{"key":"358_CR11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1191\/096120399680411317","volume":"8","author":"EL Smith","year":"1999","unstructured":"Smith EL, Shmerling RH. The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus. 1999;8:586\u201395.","journal-title":"Lupus"},{"key":"358_CR12","unstructured":"Permarheum SLEDAI Calculator: http:\/\/www.permarheum.org\/SLEDAI.html ."},{"key":"358_CR13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatson","year":"1990","unstructured":"Agatson AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"358_CR14","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","volume":"7","author":"V Pengo","year":"2009","unstructured":"Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant\/antiphospholipid antibody of the scientific and standarisation committee of the international society on thrombosis and haemostasis. J Thromb Haemost. 2009;7:1737\u201340.","journal-title":"J Thromb Haemost"},{"key":"358_CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-5273(03)00106-2","volume":"92","author":"CC Lin","year":"2003","unstructured":"Lin CC, Ding HJ, Chen YW, Wang JH, Ho ST, Kao A. Usefulness of technetium-99\u00a0m sestamibi myocardial perfusion SPECT in detection of cardiovascular involvement in patients with systemic lupus erythematosus or systemic sclerosis. Int J Cardiol. 2003;92:157\u201361.","journal-title":"Int J Cardiol"},{"key":"358_CR16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1536\/jhj.44.83","volume":"44","author":"JJ Lin","year":"2003","unstructured":"Lin JJ, Hsu HB, Sun SS, Wang JJ, Ho ST, Kao CH. Single photon emission computed tomography of technetium-99\u00a0m tetrofosmin myocardial perfusion imaging in patients with systemic lupus erythematosus\u2014a preliminary report. Jpn Heart J. 2003;44:83\u20139.","journal-title":"Jpn Heart J"},{"key":"358_CR17","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1161\/01.CIR.100.14.1521","volume":"100","author":"G Vanzetto","year":"1999","unstructured":"Vanzetto G, Ormezzano O, Fagret D, Comet M, Denis B, Machecourt J. Long term additive prognostic value of thalium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1,137 patients with 6\u00a0year follow-up. Circulation. 1999;100:1521\u20137.","journal-title":"Circulation"},{"key":"358_CR18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/01.CIR.98.2.190","volume":"98","author":"R Hachamovitch","year":"1998","unstructured":"Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;98:190.","journal-title":"Circulation"},{"key":"358_CR19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.thromres.2004.07.012","volume":"114","author":"M Petri","year":"2004","unstructured":"Petri M. The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): hopkins lupus cohort. Thromb Res. 2004;114:593\u20135.","journal-title":"Thromb Res"},{"key":"358_CR20","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3899\/jrheum.090312","volume":"36","author":"KH Yiu","year":"2009","unstructured":"Yiu KH, Wang S, Mok MY, Ooi GC, Khong PL, Mak KF, et al. Pattern of arterial calcification in patients with systemic lupus erythematosus. J Rheumatol. 2009;36:2212\u20137.","journal-title":"J Rheumatol"},{"key":"358_CR21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjcard.2008.04.059","volume":"102","author":"AH Kao","year":"2008","unstructured":"Kao AH, Wasko M, Krishnaswami S, Wagner J, Edmundowicz D, Shaw P, et al. C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis. Am J Cardiol. 2008;102:755\u201360.","journal-title":"Am J Cardiol"},{"key":"358_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacc.2008.04.004","volume":"52","author":"P Raggi","year":"2008","unstructured":"Raggi P, Gongora M, Gopal A, Callister T, Budoff M, Shaw L. Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol. 2008;52:17\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"358_CR23","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.jacc.2009.05.071","volume":"54","author":"SM Chang","year":"2009","unstructured":"Chang SM, Nabi F, Xu J, Peterson LE, Achari A, Pratt CM, et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coll Cardiol. 2009;54:1872\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"358_CR24","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2010.461","volume":"303","author":"TS Polonsky","year":"2010","unstructured":"Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1610\u20136.","journal-title":"JAMA"},{"key":"358_CR25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1148\/radiol.2531082137","volume":"252","author":"C Uebleis","year":"2009","unstructured":"Uebleis C, Becker A, Griesshammer I, Cumming P, Becker C, Schmidt M, et al. Stable coronary artery disease: prognostic value of myocardial perfusion SPECT in relation to coronary calcium scoring-long-term follow-up. Radiology. 2009;252:682\u201390.","journal-title":"Radiology"},{"key":"358_CR26","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.22265","volume":"54","author":"A Farzaneh-Far","year":"2006","unstructured":"Farzaneh-Far A, Roman MJ, Lockshin MD, Devereux RB, Paget SA, Crow MK, et al. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum. 2006;54:3918\u201325.","journal-title":"Arthritis Rheum"},{"key":"358_CR27","first-page":"425","volume":"51","author":"F Gabrielli","year":"1996","unstructured":"Gabrielli F, Alcini E, Prima MA, Lucifero A, Masala C. Cardiac involvement in connective tissue diseases and primary antiphospholipid syndrome: echocardiographic assessment and correlation with antiphospholipid antibodies. Acta Cardiol. 1996;51:425\u201339.","journal-title":"Acta Cardiol"},{"key":"358_CR28","doi-asserted-by":"crossref","unstructured":"Cefle A, Inanc M, Sayarlioglu M, Kamali S, Gul A, Ocal L et al. Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. Rheumatol Int. 2011; 31:183-189.","DOI":"10.1007\/s00296-009-1255-2"},{"key":"358_CR29","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/0961203308101719","volume":"18","author":"EM Hasegawa","year":"2009","unstructured":"Hasegawa EM, Caleiro MT, Fuller R, Carvalho JF. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease. Lupus. 2009;18:618\u201321.","journal-title":"Lupus"},{"key":"358_CR30","volume-title":"Immunology","author":"I Roitt","year":"2006","unstructured":"Roitt I. Autoimmunity and autoimmune diseases. In: Male D, Brostoff J, Roth DB, Roitt I, editors. Immunology. London: Mosby Elsevier; 2006."},{"key":"358_CR31","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0002-9149(99)00130-7","volume":"83","author":"CJ Glueck","year":"1999","unstructured":"Glueck CJ, Lang JE, Tracy T, Sieve-Smith L, Wang P. Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease. Am J Cardiol. 1999;83:1490\u20134.","journal-title":"Am J Cardiol"},{"key":"358_CR32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/096120339500400304","volume":"4","author":"M Le Tonqueze","year":"1995","unstructured":"Le Tonqueze M, Salozhin K, Dueymes M, Piette JC, Kovalev V, Shoenfeld Y, et al. Role of \u03b22-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus. 1995;4:179\u201386.","journal-title":"Lupus"},{"key":"358_CR33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0090-1229(92)90225-D","volume":"62","author":"AE Kabakov","year":"1992","unstructured":"Kabakov AE, Tertov VV, Saenko VA, Poverenny AM, Orekhow AN. The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta. Clin Immunol Immunopathol. 1992;62:214\u201320.","journal-title":"Clin Immunol Immunopathol"},{"key":"358_CR34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.61.2.110","volume":"61","author":"DJ Grainer","year":"2002","unstructured":"Grainer DJ, Bethell HW. High titers of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis. Ann Rheum Dis. 2002;61:110\u20134.","journal-title":"Ann Rheum Dis"},{"key":"358_CR35","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","volume":"27","author":"K Fox","year":"2006","unstructured":"Fox K, Garcia M, Ardissino D, Buszman P, Camici P, et al. Guidelines on the management of stable angina pectoris. The task force on the management of stable angina pectoris of the European Society of Cardiology. Eur Heart J. 2006;27:1341\u201381.","journal-title":"Eur Heart J"},{"key":"358_CR36","first-page":"1560","volume":"31","author":"JA Giron-Gonzales","year":"2004","unstructured":"Giron-Gonzales JA, Garcia del Rio E, Rodriguez C, Rodriguez-Martorell J, Serrano A. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol. 2004;31:1560\u20137.","journal-title":"J Rheumatol"},{"key":"358_CR37","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1001\/archinte.160.13.2042","volume":"160","author":"DG Wahl","year":"2000","unstructured":"Wahl DG, Bounameaux H, de Moerloose P, Sarasin FP. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis. Arch Intern Med. 2000;160:2042\u20138.","journal-title":"Arch Intern Med"},{"key":"358_CR38","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/ard.2010.136762","volume":"70","author":"M Petri","year":"2011","unstructured":"Petri M, Kiani A, Post W, Christopher-Stine L, Madger L. Lupus atherosclerosis prevention study (LAPS). Ann Rheum Dis. 2011;70:760\u20135.","journal-title":"Ann Rheum Dis"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00011-011-0358-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T21:33:50Z","timestamp":1560375230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-011-0358-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1007\/s00011-011-0358-x","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,10]]}}}